Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale FMR LLC sold 18,300 shares at $12.41 ($227,103)
  6. 4 Open-market sale 10% owner sold 16,030 shares at an average $11.65 ($186,765)
  7. 4 Open-market sale 10% owner sold 6,711 shares at an average $10.85 ($72,833)
  8. 4 Open-market sale 10% owner sold 25,132 shares at an average $10.36 ($260,453)
  9. 4 Open-market sale 10% owner sold 10,570 shares at an average $9.94 ($105,087)
  10. 4 Open-market sale 10% owner sold 1,896 shares at an average $10.51 ($19,919)
  11. 4 Open-market sale 10% owner sold 6,046 shares at an average $10.76 ($65,066)
  12. 4 Open-market sale 10% owner sold 4,723 shares at an average $10.80 ($51,020)
  13. 4 Open-market sale 10% owner sold 33,196 shares at an average $11.23 ($372,703)
  14. 4 Open-market sale 10% owner sold 9,188 shares at an average $11.19 ($102,832)
  15. 4 Open-market sale 10% owner sold 20,558 shares at an average $11.30 ($232,241)
  16. 4 Open-market sale 10% owner sold 13,189 shares at an average $11.66 ($153,765)
  17. 4 Open-market sale 10% owner sold 18,900 shares at an average $11.75 ($222,132)
  18. 4 Open-market sale 10% owner sold 27,036 shares at an average $11.46 ($309,907)
  19. 4 Other disposition 10% owner disposed of 254,965 shares (other)
  20. 4 Derivatives Options or other derivatives

Page 20 of 22 · 435 filings